Метаболический фон нормальной беременности по сравнению с беременностью у пациенток с акромегалией. Безопасности медикаментозных методов лечения акромегалии

Метаболический фон нормальной беременности по сравнению с беременностью у пациенток с акромегалией. Безопасности медикаментозных методов лечения акромегалии

Автор: Сайгина М.О.

Журнал: Форум молодых ученых @forum-nauka

Статья в выпуске: 7 (35), 2019 года.

Бесплатный доступ

Акромегалия - это редкое заболевание, при котором забеременеть удается относительно редко из-за высокой частоты вторичного гипогонадизма. Тем не менее, некоторые женщины с акромегалией беременеют, что ставит вопросы об использовании лекарств, осложнениях и наблюдении за ними. В этой статье содержатся попытки решить эти проблемы и предоставить читателю практическую информацию.

Акромегалия, беременность, осложнения, лечения

Короткий адрес: https://sciup.org/140286954

IDR: 140286954

Список литературы Метаболический фон нормальной беременности по сравнению с беременностью у пациенток с акромегалией. Безопасности медикаментозных методов лечения акромегалии

  • Nawathe AR, Christian M, Kim SH, Johnson M, Savvidou MD, Terzidou V (2016) Insulin-like growth factor axis in pregnancies affected by fetal growth disorders. Clin Epigenetics 8:11.
  • Persechini ML, Gennero I, Grunenwald S, Vezzosi D, Bennet A,Caron P (2015) Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function. Pituitary 18(4):461-464. Scippo ML, Frankenne F, Hooghe-Peters EL, Igout A, Velkeniers B, Hennen G (1993) Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol 92(2):R7-R13
  • Beckers A, Stevenaert A, Foidart JM, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71(3):725-731.
  • Verhaeghe J (2008) Does the physiological acromegaly of pregnancy benefit the fetus? Gynecol Obstet Investig 66(4):217-226.
  • Newbern D, Freemark M (2011) Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes 18(6):409-416.
  • Wiesli P, Zwimpfer C, Zapf J, Schmid C (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet Gynecol Scand 85(8):900-905.
  • Clemmons DR, Underwood LE, Ridgway EC, Kliman B, Kjellberg RN, Van Wyk JJ (1980) Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status. Am J Med 69(4):571-575
  • Balili I, Barkan A (2014) Tamoxifen as a therapeutic agent in acromegaly. Pituitary 17(6):500-504.
  • Dias ML, Vieira JG, Abucham J (2013) Detecting and solving the interference of pregnancy serum, in a GH immunometric assay. Growth Horm IGF Res 23(1-2):13-18.
  • Ringholm L, Juul A, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER (2015) Lower levels of placental growth hormone in early pregnancy in women with type 1 diabetes and large for gestational age infants. Growth Horm IGF Res 25(6):312-315.
  • Freemark M (2006) Regulation of maternal metabolism by pituitary and placental hormones: roles in fetal development and metabolic programming. Horm Res 65(Suppl 3):41-49. 13. Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301-310.
  • Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G (1988) The physiology of growth ___hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin ___Endocrinol Metab 66(6):1171-1180.
  • Kupersmith MJ, Rosenberg C, Kleinberg D (1994) Visual loss in pregnant women with pituitary ___adenomas. Ann Intern Med 121(7):473-477
  • Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihira T, Eto S (1997) A case of active __acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. __Endocr J 44(1):117-120
  • Molitch ME (2003) Pituitary tumors and pregnancy. Growth Horm IGF Res 13(Suppl A):S38-S44
  • Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, __Hamrahian A (2012) Pregnancy and acromegaly: a review.Pituitary 15(1):59-63. 19. Caron P, __Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet- __Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective __multicenter study of 59 pregnancies in 46 women. J Clin __Endocrinol Metab 95(10):4680-4687.
  • Zhu Y, Mendola P, Albert PS, Bao W, Hinkle SN, Tsai MY, Zhang C (2016) Insulin-like growth __factor axis and gestational diabetes: a longitudinal study in a multiracial cohort. Diabetes.
  • Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, PivonelloR, Colao A, Ezzat S (2012) Pregnancy __in acromegaly: experience from two referral centers and systematic review of the literature. Clin __Endocrinol 76(2):264-271.
  • Molitch ME (2015) Endocrinology in pregnancy: management of the pregnant patient with a __prolactinoma. Eur J Endocrinol 172(5):R205-R213.
  • Krupp P, Monka C (1987) Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 65(17):823-__827
  • Krupp P, Ruch R, Turkalj I (1985) Drugs in pregnancy: assessment of Parlodel. Prog Clin Biol Res __163C:211-213
  • Turkalj I, Braun P, Krupp P (1982) Surveillance of bromocriptine in pregnancy. JAMA __247(11):1589-1591
  • Yap AS, Clouston WM, Mortimer RH, Drake RF (1990) Acromegaly first diagnosed in pregnancy: __the role of bromocriptinetherapy. Am J Obstet Gynecol 163(2):477-478
  • Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, Clavenna A, Rocchi F, Gangi E, Paracchi S, __Gasperi M, Lavezzari M, Nicolosi AE, Ferrero S, Landi ML, Beck-Peccoz P, Bonati M (2002) __Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 16(6):791-__793.
  • Auriemma RS, Perone Y, Di Sarno A, Grasso LF, Guerra E, Gasperi M, Pivonello R, Colao A (2013) __Results of a singlecenter observational 10-year survey study on recurrence of hyperprolactinemia after __pregnancy and lactation. J Clin Endocrinol Metab 98(1):372-379.
  • Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, __Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. __Clin Endocrinol 72(5):668-677
  • Caron P, Gerbeau C, Pradayrol L (1995) Maternal-fetal transfer of octreotide [letter; comment]. N __Engl J Med 333(9):601-602
  • Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR treatment throughout __pregnancy in an acromegalic woman. Clin Endocrinol 55(3):411-415
  • Domingue ME, Devuyst F, Alexopoulou O, Corvilain B, Maiter D (2014) Outcome of prolactinoma __after pregnancy and lactation: a study on 73 patients. Clin Endocrinol 80(5):642-648.
  • Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, __Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. __Clin Endocrinol 72(5):668-677.
  • Caron P, Gerbeau C, Pradayrol L (1995) Maternal-fetal transfer of octreotide [letter; comment]. N __Engl J Med 333(9):601-602
  • Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR treatment throughout __pregnancy in an acromegalic woman. Clin Endocrinol 55(3):411-415
  • Takano T, Saito J, Soyama A, Ito H, Iizuka T, Yoshida T, Nishikawa T (2006) Normal delivery __following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide __long acting release formulation at an early phase of pregnancy. Endocr J 53(2):209-212
  • Neal JM (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr __Pract 6(2):148-150.
  • van der Lely AJ, Gomez R, Heissler JF, Akerblad AC, Jonsson P, Camacho-Hubner C, Koltowska-__Haggstrom M (2015) Pregnancy in acromegaly patients treated with pegvisomant. Endocrine __49(3):769-__773.
  • Riddle Brian S, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of __acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab __92(9):3374-3377.
  • Domingue ME, Devuyst F, _Alexopoulou O, Corvilain B, Maiter D (2014) Outcome of prolactinoma after pregnancy and lactation: a __study on 73 patients. Clin Endocrinol 80(5):642-648.
Еще
Статья научная
SciUp 2024 © 2024 ©